[1]
|
Holick, M.F. (2006) High Prevalence of Vitamin D Inadequacy and Implications for Health. Mayo Clinic Proceedings, 81, 353-373. https://doi.org/10.4065/81.3.353
|
[2]
|
Von Campenhausen, S., Bornschein, B., Wick, R., B?tzel, K., et al. (2005) Prevalence and Incidence of Parkinson’s Disease in Europe. European Neuropsychopharmacology, 15, 473-490. https://doi.org/10.1016/j.euroneuro.2005.04.007
|
[3]
|
Grant, W.B. (2006) Epidemiology of Disease Risks in Relation to Vitamin D Insufficiency. Progress in Biophysics and Molecular Biology, 92, 65-79.
https://doi.org/10.1016/j.pbiomolbio.2006.02.013
|
[4]
|
Kilkkinen, A., Knekt, P., Heliovaara, M., et al. (2008) Vitamin D Status and the Risk of Lung Cancer: A Cohort Study in Finland. Cancer Epidemiology, Biomarkers & Prevention, 17, 3274-3278. https://doi.org/10.1158/1055-9965.EPI-08-0199
|
[5]
|
Giovannucci, E., Liu, Y., Hollis, B.W. and Rimm, E.B. (2008) 25-Hydroxyvitamin D and Risk of Myocardial Infarction in Men: A Prospective Study. Arch Intern Med, 168, 1174-1180. https://doi.org/10.1001/archinte.168.11.1174
|
[6]
|
Knekt, P., Laaksonen, M., Mattila, C., et al. (2008) Serum Vitamin D and Subsequent Occurrence of Type 2 Diabetes. Epidemiology, 19, 666-671.
https://doi.org/10.1097/EDE.0b013e318176b8ad
|
[7]
|
Newmark, H.L. and Newmark, J. (2007) Vitamin D and Parkinson’s Disease—A Hypothesis. Movement Disorders, 22, 461-468. https://doi.org/10.1002/mds.21317
|
[8]
|
Evatt, M.L., Delong, M.R., Khazai, N., et al. (2008) Prevalence of Vitamin D Insufficiency in Patients with Parkinson Disease and Alzheimer Disease. Arch Neurol, 65, 1348-1352. https://doi.org/10.1001/archneur.65.10.1348
|
[9]
|
Sato, Y., Honda, Y., Iwamoto, J., et al. (2005) Abnormal Bone and Calcium Metabolism in Immobilized Parkinson’s Disease Patients. Movement Disorders, 20, 1598-1603.
https://doi.org/10.1002/mds.20658
|
[10]
|
Sato, Y., Kikuyama, M. and Oizumi, K. (1997) High Prevalence of Vitamin D Deficiency and Reduced Bone Mass in Parkinson’s Disease. Neurology, 49, 1273-1278.
https://doi.org/10.1212/WNL.49.5.1273
|
[11]
|
Hongliu, D., Kaltra, D., Kaitlin, C., et al. (2013) Unrecognized Vitamin D3 Deficiency Is Common in Parkinson Disease: Harvard Biomarker Study. American Academy of Neurology, 81, 1531-1537.
|
[12]
|
Eriksen, E.F. and Glerup, H. (2002) Vitamin D Deficiency and Aging: Implications for General Health and Osteoporosis. Biogerontology, 3, 73-77.
https://doi.org/10.1023/A:1015263514765
|
[13]
|
Holick, M.F. (2007) Vitamin D deficiency. The New England Journal of Medicine, 357, 266-281.
|
[14]
|
Schoenmakers, I., Goldberg, G.R. and Prentice, A. (2008) Abundant Sunshine and Vitamin D Deficiency. The British Journal of Nutrition, 99, 1171-1173.
https://doi.org/10.1017/S0007114508898662
|
[15]
|
Grant, W.B. and Holick, M.F. (2005) Benefits and Requirements of Vitamin D for Optimal Health: A Review. Alternative Medicine Review, 10, 94-111.
|
[16]
|
Brown, J.E., Isaacs, J., et al. (2013) Nutrition through the Life Cycle. Cengage Learning, Boston, MA. http://www.revolvy.com/main/index.php?s
|
[17]
|
Hughes, A.J., Daniel, S.E., Kilford, L. and Lees, A.J. (1992) Accuracy of Clinical Diagnosis of Idiopathic Parkinson’s Disease: A Clinico-Pathological Study of 100 Cases. Journal of Neurology, Neurosurgery & Psychiatry, 55, 181-184.
https://doi.org/10.1136/jnnp.55.3.181
|
[18]
|
Shen, L. and Ji, H.F. (2015) Associations between Vitamin D Status, Supplementation, Outdoor Work and Risk of Parkinson’s Disease: A Meta-Analysis Assessment. Nutrients, 7, 4817-4827. https://doi.org/10.3390/nu7064817
|
[19]
|
Evatt, M.L., DeLong, M.R., Kumari, M., et al. (2011) High Prevalence of Hypovitaminosis D Status in Patients with Early Parkinson Disease. Archives of Neurology, 68, 314-319. https://doi.org/10.1001/archneurol.2011.30
|
[20]
|
Moghaddasi, M., Mamarabadi, M. and Aghaii, M. (2013) Serum 25-Hydroxyvitamin D3 Concentration in Iranian Patients with Parkinson’s Disease. Iranian Journal of Neurology, 12, 56-59.
|
[21]
|
Lv, Z., Qi, H., Wang, L., et al. (2014) Vitamin D Status and Parkinson’s Disease: A Systematic Review and Meta-Analysis. Neurological Sciences, 35, 1723-1730.
https://doi.org/10.1007/s10072-014-1821-6
|
[22]
|
Jennifer, S.B., Tammy, M.S., Bess, D.H., et al. (2009) The Journals of Gerontology: Series A, Vitamin D Is Associated with Cognitive Function in Elders Receiving Home Health Services. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 64, 888-895.
|
[23]
|
Knekt, P., Kilkkinen, A., Rissanen, H., et al. (2010) Serum Vitamin D and the Risk of Parkinson Disease. Archives of Neurology, 67, 808-811.
https://doi.org/10.1001/archneurol.2010.120
|
[24]
|
Fullard, M.E., Xie, S.X., Marek, K., et al. (2017) Vitamin D in the Parkinson Associated Risk Syndrome (PARS) Study. Movement Disorders, 32, 1636-1640.
https://doi.org/10.1002/mds.27127
|
[25]
|
Rimmelzwaan, L.M., van Schoor, N.M., Lips, P., et al. (2016) Systematic Review of the Relationship between Vitamin D and Parkinson’s Disease. Journal of Parkinson’s Disease, 6, 29-37. https://doi.org/10.3233/JPD-150615
|
[26]
|
Ding, H., Dhima, K., Lockhart, K., et al. (2013) Unrecognized Vitamin D3 Deficiency Is Common in Parkinson Disease: Harvard Biomarker Study. Neurology, 81, 1531-1537. https://doi.org/10.1212/WNL.0b013e3182a95818
|
[27]
|
Garcion, E., Wion-Barbot, N., Montero-Menei, C.N., et al. (2002) New Clues about Vitamin D Functions in the Nervous System. Trends in Endocrinology Metabolism, 13, 100-105. https://doi.org/10.1016/S1043-2760(01)00547-1
|
[28]
|
Naveilhan, P., Neveu, I., Wion, D. and Brachet, P. (1996) 1,25-Dihydroxyvitamin D3, an Inducer of Glial Cell Line-Derived Neurotrophic Factor. Neuroreport, 7, 2171-2175. https://doi.org/10.1097/00001756-199609020-00023
|
[29]
|
Musiol, I.M. and Feldman, D. (1997) 1,25-Dihydroxyvitamin D3 Induction of Nerve Growth Factor in L929 Mouse Fibroblasts: Effect of Vitamin D Receptor Regulation and Potency of Vitamin D3 Analogs. Endocrinology, 138, 12-18.
https://doi.org/10.1210/endo.138.1.4858
|
[30]
|
Neveu, I., Naveilhan, P., Baudet, C., Brachet, P. and Metsis, M. (1994) 1, 25-Dihydroxyvitamin D3 Regulates NT-3, NT-4 but Not BDNF mRNA in Astrocytes. Neuroreport, 6, 124-126. https://doi.org/10.1097/00001756-199412300-00032
|
[31]
|
Peterson, A.L., Mancini, M. and Horak, F.B. (2013) The Relationship between Balance Control and Vitamin D in Parkinson’s Disease—A Pilot Study. Movement Disorders, 28, 1133-1137. https://doi.org/10.1002/mds.25405
|
[32]
|
Suzuki, M., Yoshioka, M., Hashimoto, M., et al. (2013) Randomized, Double-Blind, Placebo-Controlled Trial of Vitamin D Supplementation in Parkinson Disease. The American Journal of Clinical Nutrition, 97, 1004-1013.
https://doi.org/10.3945/ajcn.112.051664
|
[33]
|
Miyake, Y., Tanaka, K., Fukushima, W., et al. (2011) Lack of Association of Dairy Food, Calcium, and Vitamin D Intake with the Risk of Parkinson’s Disease: A Case Control study in Japan. Parkinsonism & Related Disorders, 17, 112-116.
https://doi.org/10.1016/j.parkreldis.2010.11.018
|
[34]
|
Juan, W., Deyu, Y., Yu, Y., et al. (2016) Vitamin D and Sunlight Exposure in Newly-Diagnosed Parkinson’s Disease. Nutrients, 8, 142.
https://doi.org/10.3390/nu8030142
|
[35]
|
Yoon, J.H., Park, D.K., Yong, S.W. and Hong, J.M. (2015) Vitamin D Deficiency and Its Relationship with Endothelial Dysfunction in Patients with Early Parkinson’s Disease. Journal of Neural Transmission (Vienna), 122, 1685-1691.
https://doi.org/10.1007/s00702-015-1452-y
|
[36]
|
Rejnmark, L., J?rgensen, M.E., Pedersen, M.B., et al. (2004) Vitamin D Insufficiency in Greenlanders on a Westernized Fare: Ethnic Differences in Calcitropic Hormones between Greenlanders and Danes. Calcified Tissue International, 74, 255-263.
https://doi.org/10.1007/s00223-003-0110-9
|
[37]
|
Gozdzik, A., Barta, J.L., Wu, H., et al. (2008) Low Wintertime Vitamin D Levels in a Sample of Healthy Young Adults of Diverse Ancestry Living in the Toronto Area: Associations with Vitamin D Intake and Skin Pigmentation. BMC Public Health, 8, 336. https://doi.org/10.1186/1471-2458-8-336
|
[38]
|
Abnet, C.C., Chen, W., Dawsey, S.M., et al. (2007) Serum 25(OH)-Vitamin D Concentration and Risk of Esophageal Squamous Dysplasia. Cancer Epidemiology, Biomarkers & Prevention, 16, 1889-1893.
https://doi.org/10.1158/1055-9965.EPI-07-0461
|
[39]
|
Rajasree, S., Rajpal, K., Kartha, C.C., et al. (2001) Serum 25-Hydroxyvitamin D3 Levels Are Elevated in South Indian Patients with Ischemic Heart Disease. European Journal of Epidemiology, 17, 567-571.
https://doi.org/10.1023/A:1014559600042
|
[40]
|
Sinotte, M., Diorio, C., Bérubé, S., Pollak, M. and Brisson, J. (2009) Genetic Polymorphisms of the Vitamin D Binding Protein and Plasma Concentrations of 25-Hydroxyvitamin D in Premenopausal Women. The American Journal of Clinical Nutrition, 89, 634-640. https://doi.org/10.3945/ajcn.2008.26445
|
[41]
|
Labuda, M., Labuda, D., Korab-Laskowska, M., et al. (1996) Linkage Disequilibrium Analysis in Young Populations: Pseudo-Vitamin D-Deficiency Rickets and the Founder Effect in French Canadians. American Journal of Human Genetics, 59, 633-643.
|
[42]
|
Hsu, J.J., Tintut, Y. and Demer, L.L. (2008) Vitamin D and Osteogenic Differentiation in the Artery Wall. Clinical Journal of the American Society of Nephrology, 3, 1542-1547. https://doi.org/10.2215/CJN.01220308
|
[43]
|
Tuohimaa, P. (2009) Vitamin D and Aging. The Journal of Steroid Biochemistry and Molecular Biology, 114, 78-84. https://doi.org/10.1016/j.jsbmb.2008.12.020
|
[44]
|
Harinarayan, C.V., et al. (2009) Vitamin D Status in India—Its Implications and Remedial Measures. A Review of over 50 Studies of 25(OH)D. Journal of the Association of Physicians of India, 57, 40-48. http://www.japi.org/jan_2009/R-1.html
|
[45]
|
Akhtar, S. (2016) Prevalence and Correlates of Vitamin D Deficiency-Perspectives from Pakistan. MINI REVIEW. Department of Food Science and Technology, Bahauddin Zakariya University, Multan, Pakistan. Pakistan Journal of Pharmaceutical Sciences, 29, 1325-1330.
|
[46]
|
Akhtar, S. (2016) Vitamin D Status of South Asian Populations—Risks and Opportunities. Critical Reviews in Food Science and Nutrition, 56, 1925-1940.
https://doi.org/10.1080/10408398.2013.807419
|
[47]
|
Anjum, P., Safder, N., Khalid, M. and Mehboob, I. (2013) Vitamin D Deficiency in Pakistani Population. Journal of Pakistan Orthopaedic Association, 25, 18-19.
|
[48]
|
Mansoor, S., Habib, A., Ghani, F., et al. (2010) Prevalence and Significance of Vitamin D Deficiency and Insufficiency among Apparently Healthy Adults. Clinical Biochemistry, 43, 1431-1435. https://doi.org/10.1016/j.clinbiochem.2010.09.022
|
[49]
|
Sheikh, A., Saeed, Z., Jafri, S.A.D., et al. (2012) Vitamin D Levels in Asymptomatic Adults—A Population Survey in Karachi, Pakistan. PLoS ONE, 7, e33452.
https://doi.org/10.1371/journal.pone.0033452
|
[50]
|
Bjelakovic, G., Gluud, L.L., Nikolova, D., et al. (2014) Vitamin D Supplementation for Prevention of Mortality in Adults. The Cochrane Database of Systematic Reviews (Systematic Review), 1, CD007470.
https://doi.org/10.1002/14651858.CD007470.pub3
|
[51]
|
Bolland, M.J., Grey, A., Gamble, G.D. and Reid, I.R. (2014) The Effect of Vitamin D Supplementation on Skeletal, Vascular, or Cancer Outcomes: A Trial Sequential Meta-Analysis. The Lancet Diabetes & Endocrinology (Meta-Analysis), 2, 307-320.
https://doi.org/10.1016/S2213-8587(13)70212-2
|
[52]
|
Ross, A.C., Taylor, C.L., Yaktine, A.L. and Del Valle, H.B. (2011) Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press, Washington, D.C.
|